Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.
By Mill Chart
Last update: Apr 30, 2024
Let's delve into the developments on the US markets in the middle of the day on Tuesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
Today's top gainers
| Ticker | Change | Comment |
|---|---|---|
| GLW | 6.26% | CORNING INC (NYSE:GLW) experienced a significant 6.26% increase, reaching $33.77 during Tuesday's session. The company's earnings where released Yesterday. Earlier today the company had a press release: Corning Reports First-Quarter 2024 Financial Results. |
| TT | 5.47% | In an impressive move, TRANE TECHNOLOGIES PLC's (NYSE:TT) shares recorded a 5.47% increase, closing at $317.31 during Tuesday's session. The company's earnings where released Yesterday. A press release (Trane Technologies Reports Strong First Quarter Results and Raises 2024 Revenue and EPS Guidance) was released earlier today. |
| LLY | 4.78% | ELI LILLY & CO's (NYSE:LLY) stock price is advancing with 4.78% to a price of $772.47. yesterday the company released their earnings. In the last 6 months the stock gained 29.83%. |
| LDOS | 3.68% | LEIDOS HOLDINGS INC's (NYSE:LDOS) stock price displayed strong growth, advancing 3.68% and reaching $136.47 during Tuesday's session. yesterday the company released their earnings. The stock is trading 26.63% higher than 6 months ago. |
| MMM | 3.26% | In an impressive move, 3M CO's (NYSE:MMM) shares recorded a 3.26% increase, closing at $95.16 during Tuesday's session. yesterday the company released their earnings. |
| ECL | 2.99% | ECOLAB INC's (NYSE:ECL) shares rose 2.99% to $228.31. ECOLAB INC released earnings Yesterday. A press release (Ecolab Delivers Very Strong First Quarter Performance; Reported Diluted EPS $1.43; Adjusted Diluted Eps $1.34, +52%; Increased 2024 Adjusted Diluted EPS Outlook: $6.40 - $6.70, +23% - 29%) was released earlier today. |
| ZBRA | 2.6% | ZEBRA TECHNOLOGIES CORP-CL A's (NASDAQ:ZBRA) stock price increased by 2.6% to $307.82. yesterday the company released their earnings. Earlier today the company had a press release: Zebra Technologies Announces First-Quarter 2024 Results. |
| ACGL | 2.45% | ARCH CAPITAL GROUP LTD (NASDAQ:ACGL) experienced a significant 2.45% increase, reaching $93.49 during Tuesday's session. Yesterday the company had a press release: Arch Capital Group Ltd. Reports 2024 First Quarter Results. |
| HSY | 2.28% | HERSHEY CO/THE (NYSE:HSY) rose 2.28% to $196.86 during Tuesday's after hours session. In the last year the share price dropped with 30.09%. |
| NXPI | 2.23% | NXP SEMICONDUCTORS NV's (NASDAQ:NXPI) shares rose 2.23% to $252.65 during Tuesday's session. In the last 6 months the stock gained 36.12%. |
To see the full list of top gainers you can use our top gainers page.
Today's top losers
| Ticker | Change | Comment |
|---|---|---|
| GEHC | -12.77% | Investors witnessed a 12.77% drop in GE HEALTHCARE TECHNOLOGY's (NASDAQ:GEHC) stock price, which closed at $77.58 during Tuesday's session. The company's earnings where released Yesterday. Earlier today the company had a press release: GE HealthCare Reports First Quarter 2024 Financial Results. |
| WBD | -8.73% | WARNER BROS DISCOVERY INC's (NASDAQ:WBD) stock price faced a 8.73% decline, reaching $7.44 during Tuesday's session. The stock is trading 20.49% lower than 3 months ago. |
| FFIV | -7.79% | F5 INC's (NASDAQ:FFIV) stock price is declining with 7.79% to a price of $167.94. Earlier today the company had a press release: F5 Delivers New Solutions that Radically Simplify Security for Every App and API. |
| TAP | -7.74% | MOLSON COORS BEVERAGE CO - B's (NYSE:TAP) stock price decreased by 7.74% to $58.64. yesterday the company released their earnings. A press release (Molson Coors Beverage Company Reports 2024 First Quarter Results) was released earlier today. |
| HUBB | -7.58% | During Tuesday's session, HUBBELL INC's (NYSE:HUBB) shares took a tumble, falling 7.58% to $376.31. yesterday the company released their earnings. Earlier today the company had a press release: Hubbell Reports First Quarter 2024 Results. |
| MPC | -7.23% | MARATHON PETROLEUM CORP (NYSE:MPC) encountered a 7.23% decrease in its shares, reaching $186.01 during Tuesday's session. MARATHON PETROLEUM CORP released earnings Yesterday. The stock is trading 20.55% higher than 3 months ago. |
| PCAR | -7.02% | PACCAR INC's (NASDAQ:PCAR) stock price is declining with 7.02% to a price of $105.67. yesterday the company released their earnings. A press release (PACCAR Achieves Excellent Financial Performance) was released earlier today. |
| SBAC | -5.78% | SBA COMMUNICATIONS CORP's (NASDAQ:SBAC) stock price faced a 5.78% decline, reaching $190.22 during Tuesday's session. Yesterday the company had a press release: SBA Communications Corporation Reports First Quarter 2024 Results; Updates Full Year 2024 Outlook; and Declares Quarterly Cash Dividend. |
| ALGN | -5.32% | ALIGN TECHNOLOGY INC's (NASDAQ:ALGN) stock price faced a 5.32% decline, reaching $288.6 during Tuesday's session. In the last 6 months the stock gained 54.39%. |
| URI | -5.15% | UNITED RENTALS INC's (NYSE:URI) stock price is declining with 5.15% to a price of $675.99. Earlier today the company had a press release: United Rentals Selected for Newsweek’s Most Trustworthy Companies in America 2024 List. |
Our top losers page will show you the full list.
ELI LILLY & CO
NYSE:LLY (5/17/2024, 7:10:55 PM)
After market: 770.75 +0.75 (+0.1%)770
-1.12 (-0.15%)
LLY News
22 hours ago - The Motley FoolIs Amgen a Threat to Eli Lilly in This Billion-Dollar Market?Eli Lilly's biggest growth drivers today are its weight loss drugs.
Eli Lilly's biggest growth drivers today are its weight loss drugs.
2 days ago - QuartzGoogle's big mistake, Walmart's layoffs, OpenAI's new ChatGPT: Business news roundupPlus, an Eli Lilly executive on how to solve the weight loss drug shortage
3 days ago - Zacks Investment ResearchTop Research Reports for Microsoft, Eli Lilly & CostcoToday's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Eli Lilly and Company (LLY) and Costco Wholesale Corporation (COST), as well a micro-cap stock Koss Corporation (KOSS).
3 days ago - InvestorPlacePharma Stocks Outlook: Where Are 2024’s Top Performers Headed Next?Investors want to know where 2024's top-performing pharma stocks are headed in the second half of the year for good reason.
3 days ago - InvestorPlaceRally Rockets: 3 Stocks Benefitting From the Market’s Unstoppable SurgeDon't miss out on profit potential of these stocks to buy. Explore three top stocks poised to unlock gains in a surging market.
3 days ago - Zacks Investment ResearchEli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C ControlEli Lilly's (LLY) two phase III studies on its once-weekly insulin, efsitora alfa, meet their primary endpoint of non-inferior reduction in blood sugar levels compared with daily basal insulins.
3 days ago - Zacks Investment ResearchEli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should KnowLilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
3 days ago - The Motley FoolMeet the GLP-1 Drug That Could Be the Biggest Concern for Eli Lilly and Novo NordiskCould Amgen be the next stock to soar due to a GLP-1 drug?
3 days ago - BloombergKeeping Muscle While Losing Fat Is Next Goal for Obesity DrugsThe new blockbuster weight-loss shots can help patients trim more pounds than any medicines have before. Now drugmakers are rushing to solve another problem — making sure people keep their muscle even as they shed fat.
4 days ago - CNBCEli Lilly falls on a rival's obesity study — plus, we're removing 3 stocks from our watchlistEvery weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
4 days ago - QuartzEli Lilly says its experimental weekly insulin works just as well as traditional dailiesThe pharma giant known for its diabetes and weight loss medications shared results of it late-stage clinical trail its long-acting insulin efsitora
